Monterey Bio Acquisition Corporation
MTRY · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $2,039 | $523 | $0 |
| Gross Profit | -$2,039 | $0 | $0 |
| % Margin | – | – | – |
| R&D Expenses | $0 | $0 | $0 |
| G&A Expenses | $0 | $523 | $0 |
| SG&A Expenses | $2 | $523 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $2,039 | $0 | $0 |
| Operating Expenses | $2,039 | $523 | $0 |
| Operating Income | -$2,039 | -$523 | -$0 |
| % Margin | – | – | – |
| Other Income/Exp. Net | $881 | -$60 | $0 |
| Pre-Tax Income | -$1,158 | -$583 | -$0 |
| Tax Expense | $116 | -$2 | $0 |
| Net Income | -$1,274 | -$581 | -$0 |
| % Margin | – | – | – |
| EPS | -0.44 | -0.04 | -0 |
| % Growth | -989.1% | -4,208,233.3% | – |
| EPS Diluted | -0.44 | -0.04 | -0 |
| Weighted Avg Shares Out | 2,875 | 14,375 | 2,500 |
| Weighted Avg Shares Out Dil | 2,875 | 14,375 | 2,500 |
| Supplemental Information | – | – | – |
| Interest Income | $1 | $2 | $0 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $228 | $0 | $206 |
| EBITDA | -$2,039 | -$523 | $0 |
| % Margin | – | – | – |